In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

ProQR Therapeutics N.V.. Trade Record

NASDAQ:PRQR ProQR Therapeutics N.V. stock gains 5.52% Exit Oct 10, 2019 a Trade Record by priceseries

Trade Chart
Trade Chart PRQR Oct 9, 2019, priceSeries
About ProQR Therapeutics N.V.

ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. The company's clinical stage candidates include QR-010, a RNA-based oligonucleotide that is in Phase Ib clinical trial for the treatment of cystic fibrosis. It also develops QR-110, which is in pre-clinical development stage for the treatment of Leber's congenital amaurosis. The company was founded in 2012 and is headquartered in Leiden, the Netherlands.

Trade Information
Trade Type
LONG
ReliabilityScore™
99.60
Entry Date
Oct 9, 2019
Entry Price
6.21
Sell Date
Oct 10, 2019
Sell Price
6.55
Net Gain
5.52%
Hold Time
1 Trading Days